Katia Varani

Via Luigi Borsari, 46
Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications

Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A2A adenosine receptor antagonists in neuroinflammatory diseases.

Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A2A adenosine receptor antagonists in neuroinflammatory diseases.

Journal: Bioorganic chemistry
Published: May 15, 2026

In Vitro Radiobiological Evaluation of [64Cu]CuCl2 for Theranostic Applications.

In Vitro Radiobiological Evaluation of [64Cu]CuCl2 for Theranostic Applications.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 29, 2026

Adenosine receptors in blood cells: Biomarkers and beyond.

Adenosine receptors in blood cells: Biomarkers and beyond.

Journal: Pharmacological research
Published: April 10, 2026

Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo.

Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo.

Journal: Journal of medicinal chemistry
Published: January 05, 2026

Colorectal Cancer: A Landscape of New Potential Radiopharmaceuticals.

Colorectal Cancer: A Landscape of New Potential Radiopharmaceuticals.

Journal: Molecular diagnosis & therapy
Published: November 05, 2025

Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors.

Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors.

Journal: ACS chemical neuroscience
Published: August 12, 2025

N-Acylaminoethyltetrahydroquinolines: A new class of melatonin receptor ligands with in vivo activity on glioblastoma.

N-Acylaminoethyltetrahydroquinolines: A new class of melatonin receptor ligands with in vivo activity on glioblastoma.

Journal: European journal of medicinal chemistry
Published: August 11, 2025

New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells.

New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells.

Journal: Bioorganic chemistry
Published: July 30, 2025

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist.

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist.

Journal: Neuropharmacology
Published: July 08, 2025

PEMFs Restore Mitochondrial and CREB/BDNF Signaling in Oxidatively Stressed PC12 Cells Targeting Neurodegeneration.

PEMFs Restore Mitochondrial and CREB/BDNF Signaling in Oxidatively Stressed PC12 Cells Targeting Neurodegeneration.

Journal: International journal of molecular sciences
Published: May 29, 2025

Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta.

Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta.

Journal: International journal of molecular sciences
Published: October 09, 2024

Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients.

Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients.

Journal: ACS pharmacology & translational science
Published: July 26, 2024
Showing 1-12 of 148

Last Updated: 09/26/2026